Legal & General Group’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-839
| Closed | -$1.7K | – | 3419 |
|
|
2025
Q1 | $1.7K | Hold |
839
| – | – | ﹤0.01% | 3360 |
|
|
2024
Q4 | $5.08K | Hold |
839
| – | – | ﹤0.01% | 3333 |
|
|
2024
Q3 | $5.87K | Hold |
839
| – | – | ﹤0.01% | 3354 |
|
|
2024
Q2 | $4.87K | Hold |
839
| – | – | ﹤0.01% | 3378 |
|
|
2024
Q1 | $5.93K | Hold |
839
| – | – | ﹤0.01% | 3282 |
|
|
2023
Q4 | $4.13K | Hold |
839
| – | – | ﹤0.01% | 3338 |
|
|
2023
Q3 | $8.02K | Hold |
839
| – | – | ﹤0.01% | 3305 |
|
|
2023
Q2 | $10.9K | Sell |
839
-85
| -9% | -$1.1K | ﹤0.01% | 3304 |
|
|
2023
Q1 | $11.7K | Buy |
+924
| New | +$11.7K | ﹤0.01% | 3181 |
|